ICON PLC
ICLR$11.18B
Large CapNASDAQServices-Commercial Physical & Biological ResearchContract research organization🇺🇸North AmericaDUBLIN 1841.9K employees
Icon plc (stylized as "ICON") is an Irish-headquartered multinational clinical research organisation (CRO). Icon conducts clinical trials on behalf of pharmaceutical and biotechnology companies and provides services related to drug development and guiding clinical trial progress.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jun 23, 2026
3dMarket Overview
Stock performance and key metrics
ICLR News
Catalyst Timeline
1 upcoming, 0 past
EarningsNext
ICLR Earnings Report
Jun 23, 2026Confirmed
EPS Est: $2.18 | FQ end 2026-03 | Call: 2026-06-24 07:00:00
Drug Pipeline
No drugs found in this phase.
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply